FDA approves Lexicon Pharmaceuticals’ Xermelo for carcinoid syndrome diarrhea

pharmanewsdaily- March 1, 2017 0

Lexicon Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its oral drug Xermelo (telotristat ethyl) 250mg, to be used in ... Read More